Safety and normal vision data study with Neos device
Part of Brain & nervous system, Eyes & vision clinical trials.
This study is testing a device called Neos to gather safety information and normal vision data. It includes both healthy volunteers and people with eye or brain conditions, helping researchers understand how vision and eye movements work.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be older than 3 years old.
- You or your legal guardian must sign a consent form to join.
- Your vision with glasses or contacts must be fairly good (better than 20/25 on a standard eye chart).
- If you have eye or brain disease, you may join if your vision is not extremely poor (better than detecting hand motion).
- You cannot be on certain medications that affect eye movements, like sedatives or stimulants (such as Ritalin or alcohol).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses multiple non-invasive imaging methods to evaluate blood flow in the optic nerve head for people with acute or chronic optic nerve conditions, including NAION, optic neuritis, LHON, and NTG.
This trial uses an eye-tracking camera or software to measure how your eyes move while you do simple tasks. It’s meant to test whether the eye-tracking system can reliably collect useful movement data in people like you.
This study compares two ways of recording eye vision test results: traditional paper methods versus a new electronic app called Acuvera Capture. You'll have your vision tested once using both methods to help researchers understand if the new tool works just as well as paper recording.
This study tests a new device called Opti-K that helps people see better up close without needing reading glasses. It may be an option if you are over 40, have had cataract surgery or no significant cataracts, and rely on reading glasses for near tasks.
This early-stage study uses virtual reality tasks to check how well a person can move and function using their eyesight. It may help researchers measure vision abilities in a way that could guide future care for retinal disease.
This study collects normal vision data from healthy adults using a device called MAIA microperimeter, which tests how your retina and eye movements respond. It helps create a baseline for comparing people with eye problems in the future.
Hear when a new Neuro-Ophthalmology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.